Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...
Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.
Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...
Roche announced a license and collaboration deal with Denmark's Zealand Pharma to co-develop its lead obesity candidate ...
European shares jumped on Wednesday after Ukraine accepted the U.S.' proposal for a 30-day ceasefire with Russia, while ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback